56 results on '"platelet reactivity"'
Search Results
2. On-treatment platelet reactivity through the thromboxane A2 or P2Y12 platelet receptor pathways is not affected by pelacarsen
3. Altered platelet reactivity, coagulation, endothelial and inflammatory markers early after smoking cessation verified with cotinine plasma concentration
4. Clinical impact of high platelet reactivity in patients with atrial fibrillation and concomitant percutaneous coronary intervention on dual or triple antithrombotic therapy
5. Time from blood draw to multiple electrode aggregometry and association with platelet reactivity
6. Circadian variations of platelet reactivity on clopidogrel in patients treated with elective percutaneous coronary intervention
7. Association of lipoprotein(a) with intrinsic and on-clopidogrel platelet reactivity
8. Impact of Chronic Kidney Disease and Platelet Reactivity on Clinical Outcomes Following Percutaneous Coronary Intervention
9. Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Acute Coronary Syndrome: Implications for Platelet Reactivity?
10. New Markers of Vascular Risk
11. Platelet reactivity in response to aspirin and ticagrelor in African-Americans and European-Americans
12. Decreased Platelet Inhibition by Thienopyridines in Hyperuricemia
13. Platelets in aging and cancer—“double-edged sword”
14. Residual platelet reactivity, thrombus burden and myocardial reperfusion in patients treated by PCI after successful pre-hospital fibrinolysis compared to primary PCI
15. Biochemistry of Altered Platelet Reactivity in Hypertension
16. Control of Platelet Reactivity by an Ecto-ADPase on Human Endothelial Cells
17. The Potential of Gliclazide, a Sulphonylurea to Influence the Oxidative Processes within the Pathogenesis of Diabetic Vascular Disease
18. The effect of cessation of 2nd generation P2Y12 inhibitor therapy on platelet reactivity in patients 1 year after acute myocardial infarction
19. Smoking, Platelet Reactivity and Fibrinogen
20. In Vitro Analysis of Plasma Protein Diffusion in Crosslinked Gelatin Coatings Used for Blood Pumps
21. Proteinuria Predicts Resistance to Antiplatelet Therapy in Ischemic Stroke
22. Long-term pharmacodynamic effects of Ticagrelor versus Clopidogrel in fibrinolytic-treated STEMI patients undergoing early PCI
23. T2238C Atrial Natriuretic Peptide Gene Variant and the Response to Antiplatelet Therapy in Stable Ischemic Heart Disease Patients
24. Platelet microRNA for predicting acute myocardial infarction
25. Predictive performance of adding platelet reactivity on top of CRUSADE score for 1-year bleeding risk in patients with acute coronary syndrome
26. Effects of cigarette smoking on platelet reactivity during P2Y12 inhibition in patients with myocardial infarction undergoing drug-eluting stent implantation: results from the prospective cigarette smoking on platelet reactivity (COPTER) study
27. The effect of dabigatran and rivaroxaban on platelet reactivity and inflammatory markers
28. Comparison of the antiplatelet effect of clopidogrel hydrogenosulfate and clopidogrel besylate in patients with stable coronary artery disease
29. Ticagrelor versus high dose clopidogrel in ST-segment elevation myocardial infarction patients with high platelet reactivity post fibrinolysis
30. Impact of cytochrome P450 2C19*2 polymorphism on intra-stent thrombus assessed by follow-up optical coherence tomography in Chinese patients receiving clopidogrel
31. Comparison of platelet inhibition by prasugrel versus ticagrelor over time in patients with acute myocardial infarction
32. A randomised trial of the pharmacodynamic and pharmacokinetic effects of ticagrelor compared with clopidogrel in Hispanic patients with stable coronary artery disease
33. Serial clopidogrel dose adjustment after platelet function testing improves outcome of acute coronary syndrome patients undergoing percutaneous coronary intervention with high on-treatment platelet reactivity
34. Platelet Function Testing in Contemporary Clinical and Interventional Practice
35. Hemostasis and Atherosclerosis
36. Endothelium as a Modulator of Platelet Reactivity
37. On the Blood Compatibility of a Heparin-Polyvinyl Alcohol Hydrogel
38. Alpha-Linolenic Acid, Platelet Lipids and Function
39. Gel Filtration of Blood Platelets: A Methodological Report
40. Increased risk of minor bleeding and antiplatelet therapy cessation in patients with acute coronary syndromes and low on-aspirin platelet reactivity. A prospective cohort study
41. New single nucleotide polymorphisms associated with differences in platelets reactivity in patients with type 2 diabetes treated with acetylsalicylic acid: genome-wide association approach and pooled DNA strategy
42. St. John’s Wort in Patients Non-responders to Clopidogrel Undergoing Percutaneous Coronary Intervention: a Single-Center Randomized Open-Label Trial (St. John’s Trial)
43. Influence of Platelet Reactivity on Clinical Outcome of Patients with Stable Coronary Artery Disease
44. Clinical Impact of Genetically Determined Platelet Reactivity
45. Angiographic and platelet reactivity outcomes with prasugrel 60 mg pretreatment and clopidogrel 600 mg pretreatment in primary percutaneous coronary intervention
46. Persistent high on-treatment platelet reactivity in acute coronary syndrome
47. Lack of correlation between platelet reactivity and glycaemic control in type 2 diabetes mellitus patients treated with aspirin and clopidogrel
48. Relationship between peripheral arterial reactive hyperemia and residual platelet reactivity after 600 mg clopidogrel
49. Plasma salicylate level and aspirin resistance in survivors of myocardial infarction
50. Effects of persistent platelet reactivity despite aspirin therapy on cardiac troponin I and creatine kinase-MB levels after elective percutaneous coronary interventions
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.